Gene Therapy Research
Gene therapy research relies on accurate viral vector measurement, robust analytical workflows, and dependable tools for process optimization and quality assessment. This page introduces the main technologies and product areas relevant to gene therapy development.
Overview
As gene therapy programs expand, researchers need practical solutions for vector production, quantification, characterization, and residual impurity testing. Clear workflows and application-focused tools can accelerate development while improving data confidence.
Key Applications
- AAV research and development
- Lentivirus production and quantification
- Vector characterization
- Residual DNA and impurity testing
- Process development support
Core Technologies
- AAV titer assays
- Lentivirus quantification kits
- qPCR and digital PCR
- ELISA-based vector detection
- Residual DNA detection assays
Example Product Areas
- AAV Titer Assays
- Lentivirus Quantification Kits
- Viral Vector ELISA Kits
- Residual DNA Detection Kits
- Host Cell Protein ELISA
Typical Workflow
- Vector production and harvest
- Initial titer estimation
- Purity and impurity assessment
- Residual DNA / protein analysis
- Comparative process evaluation
Why It Matters
Gene therapy development requires data that are both reproducible and actionable. Well-structured analytical workflows help researchers compare conditions faster and make better development decisions.